← Return to My path report says invasive ductal carcinoma with apocrine features.
DiscussionMy path report says invasive ductal carcinoma with apocrine features.
Breast Cancer | Last Active: Jul 21, 2023 | Replies (37)Comment receiving replies
Replies to "@sirene many of us have taken aromatase inhibitors like anastrazole and letrozole with few side effects...."
Thank you, I’m already taking Letrozole and doing well on it. I have had some hair thinning and some insomnia but that’s all. With the apocrine features being found in my second opinion pathology, I am not sure if my treatment will change or not. I should find out tomorrow.